Axl molecular targeting counteracts aggressiveness but not platinum‐resistance of ovarian carcinoma cells
Sign Up to like & getrecommendations! Published in 2017 at "Biochemical Pharmacology"
DOI: 10.1016/j.bcp.2017.04.002
Abstract: Graphical abstract Figure. No Caption available. Abstract Ovarian carcinoma, the most common gynaecological cancer, is characterized by high lethality mainly due to late diagnosis and treatment failure. The efficacy of platinum drug‐based therapy in the… read more here.
Keywords: igrov pt1; resistance; carcinoma; ovarian carcinoma ... See more keywords